Hamidreza Rajabzadeh-Oghaz

Hamidreza Rajabzadeh-Oghaz

Auto-generated profile, based on publicly available information

Hamidreza Rajabzadeh-Oghaz

Department of Neurosurgery, State University of New York, Buffalo, NY, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
NVN. Varble
N. Varble
HRH. Rajabzadeh-Oghaz
H. Rajabzadeh-Oghaz
JWJ. Wang
J. Wang
ASA. Siddiqui
A. Siddiqui
HMH. Meng
H. Meng
AMAshkan Mowla
Ashkan Mowla
BACKGROUND AND PURPOSE: Several recent prospective studies have found that unruptured intracranial aneurysms at various anatomic locations have different propensities for future rupture. This study aims to uncover the lack of understanding regarding rupture-prone characteristics, such as morphology and hemodynamic factors, associated with different intracranial aneurysm location. MATERIALS AND METHODS: We investigated the characteristics of 311 unruptured aneurysms at our center. Based on the PHASES study, we separated and compared morphologic and hemodynamic characteristics among 3 aneurysm location groups: 1) internal carotid artery; 2) middle cerebral artery; and 3) anterior communicating, posterior communicating, and posterior circulation arteries. RESULTS: A mixed model statistical analysis showed that size ratio, low wall shear stress area, and pressure loss coefficient were different between the intracranial aneurysm location groups. In addition, a pair-wise comparison showed that ICA aneurysms had lower size ratios, lower wall shear stress areas, and lower pressure loss coefficients compared with MCA aneurysms and compared with the group of anterior communicating, posterior communicating, and posterior circulation aneurysms. There were no statistical differences between MCA aneurysms and the group of anterior communicating, posterior communicating, and posterior circulation aneurysms for morphologic or hemodynamic characteristics. CONCLUSIONS: ICA aneurysms may be subjected to less rupture-prone morphologic and hemodynamic characteristics compared with other locations, which could explain the decreased rupture propensity of intracranial aneurysms at this location.

1 November 2018 in World Neurosurgery
Verified
Journal Article
Closed access
HRHamidreza Rajabzadeh-Oghaz
Hamidreza Rajabzadeh-Oghaz
NVNicole Varble
Nicole Varble
HSHussain Shallwani
Hussain Shallwani
VTVincent M. Tutino
Vincent M. Tutino
AMAshkan Mowla
Ashkan Mowla
HMHui Meng
Hui Meng

29 April 2021 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
HRHamidreza Rajabzadeh-Oghaz
Hamidreza Rajabzadeh-Oghaz
ASAdnan H. Siddiqui
Adnan H. Siddiqui
AAArash Asadollahi
Arash Asadollahi
JKJohn Kolega
John Kolega
VTVincent M. Tutino
Vincent M. Tutino

10 August 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
VTVincent M. Tutino
Vincent M. Tutino
YLYongjun Lu
Yongjun Lu
DIDaizo Ishii
Daizo Ishii
KPKerry Poppenberg
Kerry Poppenberg
HRHamidreza Rajabzadeh-Oghaz
Hamidreza Rajabzadeh-Oghaz
DHDavid Hasan
David Hasan
The rupture of an intracranial aneurysm (IA) causes devastating hemorrhagic strokes. Yet, most IAs remain asymptomatic and undetected until they rupture. In the search for circulating biomarkers of unruptured IAs, we previously performed transcriptome profiling on whole blood and identified an IA-associated panel of 18 genes. In this study, we seek to determine if these genes are also differentially expressed within the IA lumen, which could provide a mechanistic link between the disease and the observed circulating gene expression patterns. To this end, we collected blood from the lumen of 37 IAs and their proximal parent vessels in 31 patients. The expression levels of 18 genes in the lumen and proximal vessel were then measured by quantitative polymerase chain reaction. This analysis revealed that the expression of 6/18 genes (CBWD6, MT2A, MZT2B, PIM3, SLC37A3, and TNFRSF4) was significantly higher in intraluminal blood, while the expression of 3/18 genes (ST6GALNAC1, TCN2, and UFSP1) was significantly lower. There was a significant, positive correlation between intraluminal and proximal expression of CXCL10, MT2A, and MZT2B, suggesting local increases of these genes is reflected in the periphery. Expression of ST6GALNAC1 and TIFAB was significantly positively correlated with IA size, while expression of CCDC85B was significantly positively correlated with IA enhancement on post-contrast MRI, a metric of IA instability and risk. In conclusion, intraluminal expression differences in half of the IA-associated genes observed in this study provide evidence for IA tissue-mediated transcriptional changes in whole blood. Additionally, some genes may be informative in assessing IA risk, as their intraluminal expression was correlated to IA size and aneurysmal wall enhancement.

15 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
VTVincent M. Tutino
Vincent M. Tutino
HZHaley R. Zebraski
Haley R. Zebraski
HRHamidreza Rajabzadeh-Oghaz
Hamidreza Rajabzadeh-Oghaz
MWMuhammad Waqas
Muhammad Waqas
JJJames N. Jarvis
James N. Jarvis
KPKerry Poppenberg
Kerry Poppenberg
Peripheral blood mononuclear cells (PBMCs) play an important role in the inflammation that accompanies intracranial aneurysm (IA) pathophysiology. We hypothesized that PBMCs have different transcriptional profiles in patients harboring IAs as compared to IA-free controls, which could be the basis for potential blood-based biomarkers for the disease. To test this, we isolated PBMC RNA from whole blood of 52 subjects (24 with IA, 28 without) and performed next-generation RNA sequencing to obtain their transcriptomes. In a randomly assigned discovery cohort of n = 39 patients, we performed differential expression analysis to define an IA-associated signature of 54 genes (q < 0.05 and an absolute fold-change ≥ 1.3). In the withheld validation dataset, these genes could delineate patients with IAs from controls, as the majority of them still had the same direction of expression difference. Bioinformatics analyses by gene ontology enrichment analysis and Ingenuity Pathway Analysis (IPA) demonstrated enrichment of structural regulation processes, intracellular signaling function, regulation of ion transport, and cell adhesion. IPA analysis showed that these processes were likely coordinated through NF-kB, cytokine signaling, growth factors, and TNF activity. Correlation analysis with aneurysm size and risk assessment metrics showed that 4/54 genes were associated with rupture risk. These findings highlight the potential to develop predictive biomarkers from PBMCs to identify patients harboring IAs.

22 September 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
SVSricharan Veeturi
Sricharan Veeturi
NPNandor K Pinter
Nandor K Pinter
AMAndre Monteiro
Andre Monteiro
ABAmmad A. Baig
Ammad A. Baig
HRHamid H. Rai
Hamid H. Rai
VTVincent M. Tutino
Vincent M. Tutino
Background: VWE in contrast-enhanced magnetic resonance imaging (MRI) is a potential biomarker for the evaluation of IA. The common practice to identify IAs with VWE is mainly based on a visual inspection of MR images, which is subject to errors and inconsistencies. Here, we develop and validate a tool for the visualization, quantification and objective identification of regions with VWE. Methods: N = 41 3D T1-MRI and 3D TOF-MRA IA images from 38 patients were obtained and co-registered. A contrast-enhanced MRI was normalized by the enhancement intensity of the pituitary stalk and signal intensities were mapped onto the surface of IA models generated from segmented MRA. N = 30 IAs were used to identify the optimal signal intensity value to distinguish the enhancing and non-enhancing regions (marked by an experienced neuroradiologist). The remaining IAs (n = 11) were used to validate the threshold. We tested if the enhancement area ratio (EAR—ratio of the enhancing area to the IA surface-area) could identify high risk aneurysms as identified by the ISUIA clinical score. Results: A normalized intensity of 0.276 was the optimal threshold to delineate enhancing regions, with a validation accuracy of 81.7%. In comparing the overlap between the identified enhancement regions against those marked by the neuroradiologist, our method had a dice coefficient of 71.1%. An EAR of 23% was able to discriminate high-risk cases with an AUC of 0.7. Conclusions: We developed and validated a pipeline for the visualization and objective identification of VWE regions that could potentially help evaluation of IAs become more reliable and consistent.